• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YANG Jiajun,YUAN Mingyue,NIU Ye,CHEN Yangchunhua,ZHANG Huizong,YUAN Zimin.Study on antitumor mechanism of Epimedium based on network pharmacology and molecular docking[J].Journal Of Pharmaceutical Research,2022,41(5):292-298,306[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2421times   Download 2910次 QR Code for this article
Scan with your phone!
基于网络药理学和分子对接探讨淫羊藿抗肿瘤作用机制
杨家军1,原明月1,牛野1,陈杨春华1,张会宗2,袁子民1
Font:Larger+|Default|Smaller-
(1.辽宁中医药大学药学院,辽宁 大连 116600;2.辽宁中医药大学,辽宁 沈阳 110847)
摘要:
目的 通过网络药理学和分子对接方法探讨淫羊藿抗肿瘤的作用机制。方法 利用TCMSP数据库获取淫羊藿的活性成分以及相对应的靶点,利用Genecards、OMIM数据库获取疾病靶点,绘制药物-疾病韦恩图,获得其共同靶点;利用 Cytoscape 3.8.2 软件构建“淫羊藿活性成分-疾病靶点”网络可视化关系图;利用STRING数据库和Cytoscape 3.8.2 软件构建蛋白相互作用网络,并进行网络拓扑分析;利用R x64 4.0.5软件,对相关靶点进行GO和KEGG富集分析,了解淫羊藿抗肿瘤可能的生物过程及其通路;最后利用SYBYL 2.0软件分子对接进行半柔性对接反向验证。结果 筛选出淫羊藿活性成分23个,靶点193个;疾病相关靶点8 169个,活性成分与疾病两者共同靶点173个;蛋白互作网络显示TP53、AKT1、JUN、CASP3等靶点基因在淫羊藿抗肿瘤的生物网络中起重要作用;潜在作用靶点涉及2 592条生物学功能、176条通路。分子对接结果显示淫羊藿活性化合物与多个疾病关键靶点具有较高结合能力,对接评分较高的为淫羊藿苷与CASP3靶点蛋白。结论 淫羊藿抗肿瘤具有多靶点和多通路的潜在作用机制,为其进一步研究提供参考。
关键词:  抗肿瘤  淫羊藿  网络药理学  分子对接  作用机制
DOI:10.13506/j.cnki.jpr.2022.05.003
基金项目:辽宁省道地中药材炮制技术与标准研究项目(No.20200301);辽宁省自然科学基金指导计划项目(No.2019-ZD-0440)
Publication Date:May 25, 2022
Study on antitumor mechanism of Epimedium based on network pharmacology and molecular docking
YANG Jiajun1,YUAN Mingyue1,NIU Ye1,CHEN Yangchunhua1,ZHANG Huizong2,YUAN Zimin1
(Liaoning University of Traditional Chinese Medicine,Dalian 116600,China)
Abstract:
Objective To explore the antitumor mechanism of Epimedium by means of network pharmacology and molecular docking. Methods The active components and corresponding targets of Epimedium were obtained by TCMSP database, the disease targets were obtained by Genecards and OMIM database, and the drug disease Wayne diagram was drawn to obtain their common targets; The network visualization diagram of “Epimedium active components disease targets” was constructed by using Cytoscape 3.8.2 software; The protein-protein interaction network was constructed by using STRING database and Cytoscape 3.8.2 software, and the network topology analysis was performed; Using R x64 4.0.5 software, GO and KEGG enrichment analysis of relevant targets were carried out to understand the possible biological process and pathway of Epimedium antitumor; Finally, the reverse verification of semi flexible docking is carried out by using SYBYL 2.0 software.Results 23 active components and 193 targets of Epimedium were screened; 8169 disease-related targets and 173 common targets of active ingredients and diseases; Protein interaction network showed that TP53, AKT1, JUN, CASP3 and other target genes played an important role in Epimedium antitumor biological network; Potential targets involve 2 592 biological functions and 176 pathways. The results of molecular docking showed that the active compounds of Epimedium had high binding ability to several key disease targets, and the higher docking scores were Icariin and CASP3 target proteins. Conclusion Epimedium has the potential mechanism of multi-target and multi-channel anti-tumor, which provides a reference for its further research.
Key words:  Antitumor  Epimedium  Network pharmacology  Molecular docking  Action mechanism
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.